Efficacy of Tofacitinib for the Treatment of Psoriatic Arthritis: Pooled Analysis of Two Phase 3 Studies

MLA

Peter Nash, et al. “Efficacy of Tofacitinib for the Treatment of Psoriatic Arthritis: Pooled Analysis of Two Phase 3 Studies.” Rheumatology and Therapy, vol. 5, no. 2, Nov. 2018, pp. 567–82. EBSCOhost, https://doi.org/10.1007/s40744-018-0131-5.

APA

Peter Nash, Laura C. Coates, Roy Fleischmann, Kim A. Papp, Juan Jesus Gomez-Reino, Keith S. Kanik, Cunshan Wang, Joseph Wu, Sujatha Menon, Thijs Hendrikx, & William C. Ports. (2018). Efficacy of Tofacitinib for the Treatment of Psoriatic Arthritis: Pooled Analysis of Two Phase 3 Studies. Rheumatology and Therapy, 5(2), 567–582. https://doi.org/10.1007/s40744-018-0131-5

Chicago

Peter Nash, Laura C. Coates, Roy Fleischmann, Kim A. Papp, Juan Jesus Gomez-Reino, Keith S. Kanik, Cunshan Wang, et al. 2018. “Efficacy of Tofacitinib for the Treatment of Psoriatic Arthritis: Pooled Analysis of Two Phase 3 Studies.” Rheumatology and Therapy 5 (2): 567–82. doi:10.1007/s40744-018-0131-5.